Fresenius Dialysis Business: Market Analysis Overview
This paper evaluates Fresenius, a German healthcare company and global leader in dialysis equipment and clinic services. It examines the company's business divisions, revenue breakdown by geography, and competitive position in the U.S. dialysis market, where Fresenius ranks second behind DaVita. The paper discusses the inelastic demand characteristics of the dialysis industry, the role of Medicare as a primary payer, and the sources — including annual reports, IBIS World data, academic papers, and business media — best suited for conducting a thorough industry and company analysis. Key financial figures and market dynamics are identified to frame the broader competitive landscape.
- Company Overview and Business Divisions: Fresenius structure, divisions, and core revenue figures
- Market Focus: The United States Dialysis Industry: U.S. market size, geography, and demand inelasticity
- Competitive Landscape and Market Share: DaVita rivalry, equipment market, and Gambro competition
- Data Sources for Industry Analysis: Annual reports, IBIS World, academic papers, and media
- References: Cited sources supporting the market analysis
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Efficiently integrates financial data (revenue figures, market share percentages) with qualitative business analysis to ground the evaluation in concrete evidence.
- Demonstrates awareness of source quality and bias — for example, acknowledging that the company's annual report, while rich in information, contains elements of bias toward favorable presentation.
- Clearly explains the economic logic driving the industry, particularly the concept of inelastic demand in the context of life-sustaining medical treatment.
Key academic technique demonstrated
The paper models a structured source evaluation approach: rather than simply listing references, it explains what each source type contributes and what its limitations are. This meta-analytical framing — distinguishing industry reports, academic papers, company filings, and business media — is a strong technique for research planning and methodology sections.
Structure breakdown
The paper opens with a company profile covering Fresenius's divisions and financials, then narrows to the U.S. market focus and competitive positioning. It transitions into an evaluation of the payer environment and demand dynamics before closing with a detailed discussion of research sources. This funnel structure moves from broad company context to specific analytical methodology.
Company Overview and Business Divisions
Fresenius is a healthcare company specializing in dialysis equipment and clinics, headquartered in Bad Homburg, Germany, just outside of Frankfurt. It is one of the global leaders in this field and operates an extensive network of dialysis clinics in the United States. The dialysis business is driven by the age and overall health of individuals in a given society, and there are a variety of payers depending on the country. Most dialysis patients require multiple clinic visits per week.
The core division, Fresenius Medical Care, accounts for $15.8 billion in revenue and over $1 billion in profits. The company also operates several smaller business units: Fresenius Kabi, which covers IV drugs, clinical nutrition, and medical devices; Fresenius Helios, which operates hospitals; and Fresenius Vamed, which manages projects and services for hospitals.
Market Focus: The United States Dialysis Industry
The market location under analysis is the United States. Fresenius is a global company whose revenues are fairly evenly split between Europe (44%) and North America (40%), but within that split the United States is the single largest market. The U.S. dialysis industry is valued at approximately $21 billion. Fresenius is the second-largest player in the American market, behind DaVita.
Demand in the industry is inelastic — people who need dialysis need it to survive, and in many cases they are not the direct payer. As a result, payers have relatively little bargaining power given the acute medical necessity that dialysis patients face.
Because Fresenius uses North America as its reporting unit, separating U.S. and Canadian revenues precisely can be difficult. However, based on population, it is reasonable to estimate that approximately 90% of total North American revenues originate in the United States when such estimates are required.
Always verify citation format against your institution’s current style guide requirements.